KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Xenon Pharmaceuticals (XENE) Receivables - Other (2019 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Receivables - Other for 3 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 6.67% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 6.67% decrease, with the full-year FY2025 number at $1.4 million, down 6.67% from a year prior.
  • Receivables - Other was $1.4 million for Q4 2025 at Xenon Pharmaceuticals, up from $812000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.5 million in Q4 2024 to a low of $812000.0 in Q3 2025.